Bill Text — Sep 21, 2012
This bill’s text is now available.
Sep 21, 2012
112th Congress, 2011–2013
This bill was introduced on September 21, 2012, in a previous session of Congress, but was not enacted.
Representative for California's 50th congressional district
Read Text »
Last Updated: Sep 21, 2012
Length: 13 pages
To amend title V of the Federal Food, Drug, and Cosmetic Act to provide for extensions of marketing exclusivity periods for drugs in certain combinations of such drugs, and for other purposes.
9/21/2012--Introduced.Life-Threatening Diseases Compassion through Combination Therapy Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to authorize the Secretary of Health and Human Services (HHS) to designate ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 6502”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 6502 — 112th Congress: Life-Threatening Diseases Compassion through Combination Therapy Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr6502
“H.R. 6502 — 112th Congress: Life-Threatening Diseases Compassion through Combination Therapy Act of 2012.” www.GovTrack.us. 2012. October 8, 2015 <https://www.govtrack.us/congress/bills/112/hr6502>
|title=H.R. 6502 (112th)
|accessdate=October 8, 2015
|author=112th Congress (2012)
|date=September 21, 2012
|quote=Life-Threatening Diseases Compassion through Combination Therapy Act of 2012